Name | Lonicerin |
---|---|
Synonyms |
2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl 6-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside
4H-1-Benzopyran-4-one, 7-[[6-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5-hydroxy- MFCD03792755 |
Description | Luteolin-7-rutinoside has both anti-arthritic and antifungal activities, can result in a combination therapy for the treatment of fungal arthritis due to C. albicans infection. |
---|---|
Related Catalog | |
In Vitro | At a dose of 10 μg Luteolin-7-rutinoside (lonicerin)/mL, there is an approximately 47% decrease of the proliferation as compared to proliferation of Luteolin-7-rutinoside treated (control) T cells (p<0.05). Luteolin-7-rutinoside at 40 μg/mL dose give almost the same rate of T cell proliferation as does 20 μg/mL dose of Luteolin-7-rutinoside. The suppressive activity is dose dependent. Luteolin-7-rutinoside treatment swifts Th1-Th2 balance away from Th1-toward Th2-type responses. Luteolin-7-rutinoside inhibits nitric oxide (NO) production from macrophages[1]. |
References |
Density | 1.8±0.1 g/cm3 |
---|---|
Boiling Point | 954.0±65.0 °C at 760 mmHg |
Melting Point | 192-196 °C |
Molecular Formula | C27H30O15 |
Molecular Weight | 594.518 |
Flash Point | 316.9±27.8 °C |
Exact Mass | 594.158447 |
LogP | 1.35 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.747 |
RIDADR | NONH for all modes of transport |
---|